Actively Recruiting
Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer Patients
Led by National Cancer Centre, Singapore · Updated on 2025-06-11
5000
Participants Needed
1
Research Sites
587 weeks
Total Duration
On this page
Sponsors
N
National Cancer Centre, Singapore
Lead Sponsor
N
National Medical Research Council (NMRC), Singapore
Collaborating Sponsor
AI-Summary
What this Trial Is About
Patients with cancers that are sensitive to radiotherapy treatment and/or patients who have experienced severe acute/ late side effects to radiotherapy will be recruited to the study. Blood and/or matched tumour-normal tissue pairs will be collected. Blood and/or tissue samples will be processed and studied for genetic and biochemical markers that have potential to be used for predicting sensitivity to radiation.
CONDITIONS
Official Title
Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with severe side effects from radiotherapy
- Patients with a type of cancer that is associated with sensitivity to radiotherapy
You will not qualify if you...
- Age of patient must be between 21 (inclusive) and 99 (exclusive)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
National Cancer Center Singapore
Singapore, Singapore, 169690
Actively Recruiting
Research Team
M
Melvin Chua, MD
CONTACT
E
Enya Ong
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here